Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas(Multidisciplinary Association for Psychedelic Studies), David E. Olson(Multidisciplinary Association for Psychedelic Studies), Mark Rus(Epix Pharmaceuticals (United States)), Arabo A. Avanes(University of California, Davis), Retsina Meyer(Epix Pharmaceuticals (United States))
Cited by 160
Related Papers
Psychedelics Promote Structural and Functional Neural Plasticity
|Cell Reports|2018|1.1k
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
|Science|2023|464
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
|ACS Pharmacology & Translational Science|2020|326
The neural basis of psychedelic action
|Nature Neuroscience|2022|286